Abstract
The proposed technological solution involves the development of a product containing exosomes derived from mesenchymal stromal cells (MSCs) formulated in a topical spray to facilitate application and penetration into the skin of dogs with atopic dermatitis. This solution aims to address the specific challenges associated with CAD in an innovative and effective manner. MSC exosomes have po…